Literature DB >> 23285453

A Patient with Multiple Immune Reconstitution Inflammatory Syndrome (IRIS) Following Initiation of Antiretroviral Therapy.

Basavaprabhu Achappa1, Deepak Madi, Nishitha Shetty, Soundarya Mahalingam.   

Abstract

The Immune Reconstitution Inflammatory Syndrome (IRIS) is an exaggerated pathological inflammatory reaction which occurs after the initiation of the antiretroviral therapy, due to the exuberant immune responses to the occult or the apparent opportunistic infections. The hallmark of the syndrome is the paradoxical worsening of an existing infection or a disease process or the appearance of a new infection or a disease process soon after the initiation of the antiretroviral therapy.The most common forms of IRIS occur in association with tuberculosis and chronic viral and invasive fungal infections. Multiple IRIS in a patient is extremely rare. Our patient had multiple manifestations of IRIS, in the form of cryptococcal meningitis, toxoplasmosis and Cytomegalovirus (CMV) retinitis after the initiation of highly active antiretroviral therapy.

Entities:  

Keywords:  Cryptococcal Meningitis; Cytomegalovirus (CMV) retinitis; HIV; Immune reconstitution inflammatory syndrome (IRIS); Toxoplasmosis

Year:  2012        PMID: 23285453      PMCID: PMC3527793          DOI: 10.7860/JCDR/2012/4547.2556

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

Review 1.  Immune restoration disease after antiretroviral therapy.

Authors:  Martyn A French; Patricia Price; Shelley F Stone
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

Review 2.  Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

Authors:  Monika Müller; Simon Wandel; Robert Colebunders; Suzanna Attia; Hansjakob Furrer; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2010-04       Impact factor: 25.071

3.  Biopsy-proven immune reconstitution syndrome in a patient with AIDS and cerebral toxoplasmosis.

Authors:  Gerald Pfeffer; Alister Prout; John Hooge; John Maguire
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

4.  Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy.

Authors:  M A French; N Lenzo; M John; S A Mallal; E J McKinnon; I R James; P Price; J P Flexman; M L Tay-Kearney
Journal:  HIV Med       Date:  2000-03       Impact factor: 3.180

Review 5.  Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.

Authors:  Stephen D Lawn; Graeme Meintjes
Journal:  Expert Rev Anti Infect Ther       Date:  2011-04       Impact factor: 5.091

Review 6.  Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature.

Authors:  Guillaume Martin-Blondel; Muriel Alvarez; Pierre Delobel; Emmanuelle Uro-Coste; Lise Cuzin; Victor Cuvinciuc; Judith Fillaux; Patrice Massip; Bruno Marchou
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-26       Impact factor: 10.154

7.  Hydrocephalus: an unusual CT presentation of cerebral toxoplasmosis in a patient with acquired immunodeficiency syndrome.

Authors:  J Nolla-Salas; C Ricart; L D'Olhaberriague; F Galí; J Lamarca
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

8.  Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.

Authors:  David M Murdoch; Willem D F Venter; Annelies Van Rie; Charles Feldman
Journal:  AIDS Res Ther       Date:  2007-05-08       Impact factor: 2.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.